Peripheral blood smears sometimes reveal neutrophils with bilobed nuclei that resemble the Pelger-Huët anomaly, yet these cells appear in the context of an underlying disorder rather than as a benign inherited trait. These so-called pseudo Pelger-Huët cells represent a morphological mimicry of the classic Pelger-Huët anomaly, prompting careful scrutiny by hematopathologists to distinguish reactive or malignant causes from a congenital pattern.
Definition and Morphological Features
Pseudo Pelger-Huët cells are neutrophils exhibiting hyposegmentation, typically with a bilobed nucleus and coarse, clumped chromatin that closely mirrors the inherited Pelger-Huët anomaly. The cytoplasm may appear slightly basophilic with reduced specific granulation, and the cells are often larger than normal neutrophils. Key distinguishing features from true Pelger-Huët anomaly include variability in nuclear shape among cells, the presence of other reactive changes, and an association with an underlying systemic condition or malignancy.
Common Causes and Pathogenesis
The emergence of pseudo Pelger-Huët cells is most frequently linked to myelodysplastic syndromes, particularly the refractory cytopenia with multilineage dysplasia, where dysgranulopoiesis drives the abnormal nuclear maturation. They are also observed in acute myeloid leukemia, especially in therapy-related cases, reflecting cytotoxic injury to the bone marrow. Other etiologies include severe infections, autoimmune disorders, and myeloproliferative neoplasms, all of which can perturb the delicate balance of granulocytic differentiation and nuclear segmentation.
Myelodysplastic Syndromes
In myelodysplastic syndromes, pseudo Pelger-Huët cells arise from ineffective hematopoiesis and cytoplasmic asynchrony, where nuclear maturation lags behind cytoplasmic development. The dysplastic granulocytic precursors often show additional abnormalities such as hypogranulation, cytoplasmic basophilia, and nuclear irregularity, reinforcing the diagnostic impression of a clonal disorder rather than a benign variant.
Acute Leukemias and Drug Effects
During the blast phase of acute myeloid leukemia, pseudo Pelger-Huët-like morphology can emerge amid a background of abnormal blasts and dysplastic maturing neutrophils. Chemotherapeutic agents, notably alkylating agents and topoisomerase II inhibitors, frequently induce pseudo Pelger-Huët changes as part of a broader pattern of nuclear dysgenesis, which may persist for weeks to months after therapy cessation.
Diagnostic Evaluation and Laboratory Findings
Laboratory assessment begins with a complete blood count and peripheral blood smear review, where the presence of pseudo Pelger-Huët cells prompts evaluation for dysplasia and blasts. Ancillary testing, including bone marrow aspiration, cytogenetic analysis, and molecular profiling, is often necessary to identify underlying clonal abnormalities such as del(5q), -7, or complex karyotypes that support a diagnosis of myelodysplastic syndrome.
Clinical Significance and Prognostic Implications
The detection of pseudo Pelger-Huët cells should alert clinicians to an underlying hematologic disorder, particularly when accompanied by cytopenias and dysplastic features in other cell lines. While the cells themselves are not directly responsible for symptoms, their presence often reflects a more severe hematologic pathology, influencing risk stratification, treatment planning, and the need for disease-modifying therapy.
Differential Diagnosis and Reporting Pitfalls
Distinguishing pseudo Pelger-Huët cells from true Pelger-Huët anomaly, hereditary neutrophilic hypersegmentation, and artifacts of smear preparation requires integration of clinical context, longitudinal observations, and correlation with other laboratory data. Misinterpretation can lead to unnecessary concern for an inherited condition or, conversely, delayed recognition of a curable hematologic malignancy, underscoring the importance of meticulous morphological evaluation.
